Afuco™ Anti-Human FGFR4 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-FGFR4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The FGFR4 antibodies are suitable for diagnosing, preventing and/or treatment of diseases associated with FGFR4 expression. FGFR4 has been found to be expressed and/or influencing prognostic outcome in several types of cancer such as melanoma, breast, prostate, thyroid and pancreatic cancers.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-273CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | FGFR4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |